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Abstract
Background: Corynebacterium species are recognized as uncommon agents of endocarditis, but
little is known regarding species-specific risk factors and outcomes in Corynebacterium endocarditis.
Methods: Case report and Medline search of English language journals for cases of Corynebacterium
endocarditis. Inclusion criteria required that cases be identified as endocarditis, having persistent
Corynebacterium bacteremia, murmurs described by the authors as identifying the affected valve, or
vegetations found by echocardiography or in surgical or autopsy specimens. Cases also required
patient-specific information on risk factors and outcomes (age, gender, prior prosthetic valve, other
prior nosocomial risk factors (infected valve, involvement of native versus prosthetic valve, need
for valve replacement, and death) to be included in the analysis. Publications of Corynebacterium
endocarditis which reported aggregate data were excluded. Univariate analysis was conducted with
chi-square and t-tests, as appropriate, with p = 0.05 considered significant.
Results: 129 cases of Corynebacterium endocarditis involving nine species met inclusion criteria.
Corynebacterium endocarditis typically infects the left heart of adult males and nearly one third of
patients have underlying valvular disease. One quarter of patients required valve replacement and
one half of patients died. Toxigenic C. diphtheriae is associated with pediatric infections (p < 0.001).
Only  C. amycolatum has a predilection for women (p = 0.024), while C. pseudodiphtheriticum
infections are most frequent in men (p = 0.023). C. striatum, C. jeikeium and C. hemolyticum are
associated with nosocomial risk factors (p < 0.001, 0.028, and 0.024, respectively). No species was
found to have a predilection for any particular heart valve. C. pseudodiphtheriticum is associated with
a previous prosthetic valve replacement (p = 0.004). C. jeikeium infections are more likely to require
valve replacement (p = 0.026). Infections involving toxigenic C. diphtheriae and  C.
pseudodiphtheriticum are associated with decreased survival (p = 0.001 and 0.032, respectively).
Conclusion:  We report the first analysis of species-specific risk factors and outcomes in
Corynebacterium endocarditis. In addition to species-specific associations with age, gender, prior
valvular diseases, and other nosocomial risk factors, we found differences in rates of need for valve
replacement and death. This review highlights the seriousness of these infections, as up to 28% of
patients required valve replacement and 43.5% died.
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Background
Corynebacterium  species, or "diphtheroids", are aerobic,
non-sporulating, pleomorphic, Gram-positive bacilli that
are often considered non-pathogenic components of nor-
mal skin flora and mucosal membranes. Although fre-
quently isolated in cultures, they are commonly and often
justifiably assumed to be contaminants [1,2]. Neverthe-
less, the ability of these bacteria to cause life-threatening
disease is well established, and over the last decade there
have been increasing reports of their pathogenic potential
in numerous clinical scenarios, including bacteremia and
endocarditis [3-5]. Diphtheroids are now thought to
cause 9% of early and 4% of late prosthetic valve endocar-
ditis (PVE), [1,4] but only 0.2 to 0.4% of cases of native
valve endocarditis (NVE) [4,6]. Recognized risk factors for
Corynebacterium endocarditis include preexisting cardiac
disease, a prior history of bacterial endocarditis, and the
presence of prosthetic devices, including intravascular
access and auriculo-ventricular cerebrospinal fluid shunts
[1,6,7]. It is unknown whether certain species of Coryne-
bacterium are more frequently associated with endocardi-
tis, are associated with different predisposing conditions
or risk factors, or if they have differences in outcomes –
such as requiring valve replacement surgery or greater
mortality. To date, most published reports of Corynebacte-
rium endocarditis have been case reports and series, and
no detailed species-specific analysis of risk factors and
outcomes in Corynebacterium endocarditis has been con-
ducted. Herein, we review the literature for patient-level
reports of Corynebacterium endocarditis and conducted the
first species-specific analysis of risk factors and outcomes
in Corynebacterium endocarditis.
Methods
A Medline search of English language journals for
reported cases of Corynebacterium endocarditis. In those
reports with case series, every effort was made to obtain
the primary reference or discuss the particulars of the case
with the original authors. We standardized our definitions
for inclusion/exclusion to include only cases with persist-
ent Corynebacterium bacteremia (at least >1 positive blood
culture with an identified Corynebacterium species), mur-
murs described by the authors of the source publication as
identifying the affected valve, or vegetations found either
in an echocardiographic report, or in surgical or autopsy
specimens. A number of cases described Corynebacterium
bacteremia in the setting of pacemaker infections and
non-valvular endovascular foci of infections. While these
are considered by many to be "endocarditis equivalents",
they did not meet our definition of endocarditis and were
dropped from the analysis. In addition, only cases whose
source report included individual patient-specific infor-
mation on risk factors and outcomes were included in the
analysis. Patient-level characteristics and medical infor-
mation of interest are detailed below. However, publica-
tions of Corynebacterium  endocarditis which reported
aggregate data were excluded.
Patient characteristics in the analysis included demo-
graphic data, such as gender and age. Pediatric cases were
defined as those occurring in patients less than 18 years
old of age and adult cases as those occurring in patients 18
years or older. Medical information recorded included the
presence of comorbid illnesses, pre-existing valvular dis-
ease other than valve replacement, infected valve, and
involvement of native versus prosthetic valve. Nosoco-
mial risk factors were defined as the presence of prosthetic
medical devices other than artificial heart valves, such as
pacemakers, ventriculoperitoneal shunts, and the use of
intravascular devices. Primary outcomes of interest were
need for valve replacement and mortality. Nomenclature
for Corynebacterium species was based on those approved
by the International Code of Nomenclature of Bacteria
and species identification was classified as reported in the
original source document [8]. Statistical analysis was
done using SPSS® version 13.0 (Chicago, IL). Univariate
analysis was conducted with chi-square and t-tests, as
appropriate, with p = 0.05 (two sided) was considered sta-
tistically significant. In three cases, Corynebacterium endo-
carditis was found to have only a single case for that
unique species. These were excluded from the analysis
because of their small numbers simultaneously added lit-
tle to the analysis and because of the potential bias from
the intrinsic marked skew that results from inclusion of
data where a single case provides 100% of the data points
for an entire species. Study received approval of the Insti-
tutional Review Board and was conducted in accordance
with the Helsinki declaration.
Case Report
A 62 year-old man with a history of hypertension, alco-
holism, and mild renal insufficiency, presented to our
hospital with a two-day history of fevers, lower back pain,
and new onset of urinary retention. One week prior to
admission, the patient had undergone diagnostic cardiac
catheterization for new onset of atrial fibrillation and had
been started on coumadin. Other medications prior to
admission were digoxin, diltiazem, furosemide, lisinopril,
metoprolol, omeprazole, simvastatin, coumadin. Vital
signs on admission were: blood pressure 100/60, temper-
ature 101.4°F, heart rate 100, respiratory rate 20, He had
an irregular heart rhythm without murmurs and mild
right flank pain. There was a small non-tender and non-
purulent ecchymotic area in the right groin at the site of
previous catheterization. His neurologic exam was nonfo-
cal except for new 4/5 bilateral lower extremity weakness.
White blood cell count was 18.4 K/mm3, with 75% neu-
trophils and 12% bands. Hemoglobin and platelets were
normal. Sodium 128 mmol/L, blood urea nitrogen 46
mmol/L, creatinine 1.7 mmol/L. INR was 11.21. AmylaseBMC Infectious Diseases 2007, 7:4 http://www.biomedcentral.com/1471-2334/7/4
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and lipase were 557 and 325. A chest x-ray, and a com-
puted tomography (CT) scan of the lumbar spine were
unremarkable. A CT scan of the abdomen showed mild
early pancreatitis without dilatation of the biliary tree.
Blood and urine cultures were sent and the patient was
diagnosed with mild pancreatitis and coagulopathy sec-
ondary to coumadin overdose. He was was started on
intravenous levofloxacin 500 mg, with resolution of the
fever by the next day. He received vitamin K and his cou-
madin was temporarily stopped.. Over the next days, his
INR decreased to 1.3 and his abdominal pain and leuko-
cytosis improved, but the back pain and urinary retention
continued. By the sixth day of admission, he complained
of stool incontinence. A magnetic resonance image (MRI)
study of the lumbar spine showed inflammatory diskitis
with fluid in the L5/S1 disc space, along with osteomyeli-
tis and a posterior epidural abscess with moderate-to-
severe vertebral canal stenosis. The Spine Surgery Service
was consulted, but they felt that the neurological findings
were not explained by the lesion seen on MRI and recom-
mended non-operative management.
Blood cultures from admission later grew Gram-positive
bacilli, and repeat cultures confirmed Corynebacterium
striatum bacteremia on the sixth day of admission. At this
time, antibiotics were changed to vancomycin 1500 mg iv
daily with subsequent improvement of the back pain, uri-
nary retention and stool incontinence. Follow up blood
cultures were negative. A transesophageal echocardiogram
(TEE) revealed moderate aortic insufficiency and a 3–4
mm vegetation on the non-coronary cusp of the aortic
valve, with a perforation at the same site. Cardiovascular
surgery recommended that a valve replacement be
deferred pending initial antibiotic treatment. A follow-up
MRI of the spine reported no significant change on the
fluid collection. Surgery was offered, but the patient
refused stating he felt decreased weakness and wanted to
pursue a conservative management. Over the next days,
the patient showed progressive improvement in his lower
extremity strength and was able to ambulate with the help
of a physical therapist. His urinary retention and bowel
dysfunction improved as well.
Three weeks later, the patient became febrile and acutely
dyspneic. An emergent TEE showed an increase in the
regurgitant jet through the aortic valve perforation. The
patient underwent emergency coronary aortic bypass
grafting and aortic valve replacement. Pathology of the
aortic valve revealed a heavily calcified aortic valve, and
the gram stain showed gram positive coccobacilli. Cul-
tures of the valves were negative, however, the valve had
been mistakenly placed on formalin prior to submission
to the Microbiology Laboratory. The patient did well post-
operatively and was discharged on intravenous vancomy-
cin. At a two-month follow-up appointment the patient's
back pain had resolved and an MRI showed resolution of
the epidural abscess. Post treatment surveillance blood
cultures were sterile after a total of 12 weeks of intrave-
nous vancomycin after his discharge from the hospital. At
follow up over two years later the patient remained infec-
tion free.
Results
Our search returned 172 cases of Corynebacterium endo-
carditis with meaningful patient-level clinical data. Of
these, 43 (25.0%) were excluded (Table 1). In 21 cases
(48.8%) the isolates were not identified to a species level,
14 cases (32.5%) they were identified only as "diph-
theroids", and seven cases (16.3%) were single or double
cases identified only by their CDC group (Table 1). C. tus-
caniae, C. accolens, and C. pyogenes were excluded as they
each contributed only a single case and were not amena-
ble to analysis. Fourteen cases (32.5%) were excluded
because they lacked documentation identifying which
specific valve was infected or information on our primary
outcomes (valve replacement and death). Five cases
(11.6%) were infections of pacemakers, prosthetic devices
other than heart valves, or involved non-heart valve loca-
tions.
129 cases (75.0%) had sufficiently detailed patient-level
information to be included in the final analysis. Details of
the clinical and epidemiological findings of these cases
are found in Table 2 [[6-96],97]. Species encountered
Table 1: Excluded cases of Corynebacterium endocarditis 
(N = 43)
Non speciated Corynebacterium and isolates not yet 
recognized as a species
"Diphtheroids" 14 (32.5)
Corynebacterium CDC group 1 2 (4.6)
Corynebacterium CDC group A4 1 (2.3)
Corynebacterium CDC group I1 1 (2.3)
Corynebacterium CDC group D2 1 (2.3)
Corynebacterium CDC group G1 1 (2.3)
Corynebacterium CDC group G2 1 (2.3)
Only one case identified by species
C. tuscaniae 1 (2.3)
C. accolens 1 (2.3)
C. pyogenes 1 (2.3)
Missing primary study outcomes* 13 (30.2)
Special cases† 5 (11.6)
No valve identified 1 (2.3)
TOTAL 43 (100)
* Valve replacement, death.
† Special cases: pacemaker infections (two cases), vegetation on the 
posterior wall of the right atrium (one case), vegetation on the 
proximal part of the right pulmonary artery but not on the pulmonic 
valve (one case), infection of an aortic allograft placed during a repair 
of a tetrallogy of Fallot (one case).BMC Infectious Diseases 2007, 7:4 http://www.biomedcentral.com/1471-2334/7/4
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included 60 cases (46.5%) of non-toxigenic C. diphtheriae
(NTCD), 18 cases (14.0%) of C. pseudodiphtheriticum, 14
cases (10.9%) of C. striatum, 14 cases (10.9%) of toxigenic
C. diphtheriae (TCD), 13 cases (10.1.%) of C. jeikeium, and
four cases (3.1%) of C. xerosis. Finally, C. amycolatum, C.
minutissimum, and C. hemolyticum each were responsible
for two cases of endocarditis.
Patients' age ranged from 4 to 88 years (mean age 35.7 ±
22.9), and 93 (72.1%) were male.
Among all cases, previous valvular disease was present in
40 (31.0%) of the cases, including a previous valvular
replacement in 25 cases (19.3%). Predisposing nosoco-
mial risk factors were present in ten patients (7.7%). Left-
sided endocarditis was present in 94.6% of the cases.
Therapeutic valve replacement was required in 36 cases
(27.9%). Mortality attributable to Corynebacterium endo-
carditis infection was high, with 56 patients (43.4%) suc-
cumbing to their infection.
C. amycolatum infections were more frequent in women
(100%, p = 0.024), while C. pseudodiphteriticum infections
were more frequently found in men (93.8%, p = 0.023).
Species-specific age-related associations were also noted.
In general, most Corynebacterium species were more likely
to cause endocarditis in adults (attaining statistical signif-
icance for C. striatum, C. jeikeium, and NTCD, p = 0.018, p
= 0.024, and p = 0.012, respectively), while TCD was the
only species that infected children more frequently (p <
0.001).
All of the species showed a predilection for left-sided
endocarditis (Table 2), but no species had a statistically
significant predilection for any particular valve. There
were no significant differences among species' associa-
tions with a history of previous valvular disease other than
in cases of prior valve replacement, where C. pseudodiph-
theriticum was found to more commonly infect prosthetic
valves (p = 0.004). C. striatum, C. jeikeium, and C. hemolyti-
cum were more commonly associated with a nosocomial
risk factors (p < 0.001, p = 0.028, p = 0.024, respectively).
C. jeikeium endocarditis was also the most likely to require
valve replacement as a result of the infection (53.8%, p =
0.026). Overall, valve replacement was required in 27.9%
of cases, but there were no significant differences in the
likelihood of need for valve replacement among the other
species.
Overall survival in Corynebacterium endocarditis across all
species was 56.6%. C. striatum was associated with the
highest survival rate (78.6%, p = 0.074). In contrast, TCD
and C. pseudodiphtheriticum were associated with a poorer
survival than other species (14.3%, p = 0.001 and 33.3%,
p = 0.032, respectively).
Discussion
We conducted the largest detailed patient-level analysis of
Corynebacterium endocarditis to date, and report the first
species-specific associations for these infections. Fore-
most, we believe that our findings highlight the serious-
ness of Corynebacterium endocarditis, as over one quarter
of patients required valve replacement and mortality was
43.4%. Overall,Corynebacterium  endocarditis typically
infects adult males and has a strong predilection for left
sided involvement; nearly one-third of patients have
underlying valvular disease.
Our study found significant differences in species-specific
risk factors in Corynebacterium endocarditis, including age
and gender associations, underlying clinical risk factors,
predilection for prosthetic valves, as well as notable differ-
ences in clinical outcomes, such as need for valve replace-
ment and survival.
The species-specific analysis revealed a strong gender pre-
dilection for two Corynebacterium species. C. amycolatum
infections occurred exclusively in females while C. pseu-
dodiphteriticum occurred overwhelmingly in males. Age-
related species-specific findings were also noted. NTCD,
C. striatum and C. jeikeium have significant predilection
for adults. In contrast to NTCD, TCD is significantly more
common in children, as consistent with previous litera-
ture and historic associations. In addition, adults are more
likely than children to have a Corynebacterium endocardi-
tis of nosocomial origin (p = 0.050), which is likely to
reflect a greater likelihood of prosthetic medical devices,
invasive procedures, and intravascular access in the adult
population. While not reaching statistical significance,
adults were also more likely to have endocarditis of a
prosthetic valve (p = 0.073). This is likely to reflect a
greater prevalence of prosthetic valves in the adult popu-
lation.
Species-specific associations with a nosocomial origin
were found for C. striatum, C. jeikeium, and C. hemolyticum.
While these species are associated with nosocomial risk
factors, they were not associated with a higher incidence
of need for valve replacement or greater mortality. Of all
Corynebacterium  species, only C. pseudodiphtheriticum
showed a predilection for prosthetic versus native valves.
This species was also found to have a statistically signifi-
cant increase in mortality, with two thirds of cases not sur-
viving their infection. An unexpected finding is the greater
probability of valve replacement (p = 0.014) and mortal-
ity (p = 0.001) found in TCD endocarditis. It is possible
that this might be due, in part, to including older reports
from time periods when antibiotic drugs and other thera-
peutic measures were unavailable or less effective fro
managing endocarditis. However, even recent reports of
TCD endocarditis have shown a high risk of complica-B
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Table 2: Corynebacterium endocarditis: risk factors and outcomes by Corynebacterium species.
Species & references Number of cases†
(% total)
Mean age
(years)
Male n
(%)
Left sided 
Endocarditis‡
n (%)
Previous 
prosthetic valve
n (%)
Previous 
valvular disease§
n (%)
Nosocomial 
risk factors||
n (%)
Required 
valve replacement
n (%)
Survived
n(%)
Non-toxigenic C. diphtheriae 5, 20, 22, 24–26, 
27, 32, 46, 48–52, 54, 62, 63, 65, 66, 68, 78, 
94
60 (46.5%) 56 ± 13.8
p = 0.012
45 (75%) 58 (95.1%) 8 (13.3%) 17 (28.3%) 1 (1.7%)
p = 0.017
17 (28.3%) 39 (65%)
p = 0.060
C. pseudo-diphtheriticum 18, 20, 36–38, 40, 
42–45, 81, 83
18 (14.0%) 45 ± 21.32 17 (93.8%)
p = 0.023
18 (100%) 8 (44.4%)
p = 0.004
6 (33.3%) 0 (0%) 6 (37.5%) 6 (33.3%)
p = 0.032
Toxigenic C. diphtheriae 23, 27, 29, 49, 64, 66 14 (10.9%) 17.5 ± 16.5
p < 0.001
8 (57.1%) 12 (85.7%) 1 (7.1%) 2 (14.3%) 0 (0%) 0 (0%)
*p = 0.014
2 (14.3%)
p = 0.001
C. striatum 6, 7, 9–15, 53, 56, 62 14 (10.9%) 61.3 ± 13.9
p = 0.018
7 (50%) 12 (85.7%) 3 (21.4%) 4 (28.6%) 5 (35.7%)
p < 0.001
4 (28.6%) 11 (78.6%)
p = 0.074
C. jeikeium 6, 16, 19, 25, 34, 35, 69, 79, 93 13 (10.1%) 57.2 ± 13.6
p = 0.024
10 (76.9%) 12 (92.3%) 5 (38.5%)
p = 0.064
6 (42.6%) 3 (23.1%)
p = 0.028
7 (53.8%)
p = 0.026
10 (76.9%)
C. xerosis 59, 75, 82, 95 4 (3.1%) 51.2 ± 12.3 3 (75%) 4 (100%) 0 (0%) 2 (50%) 0 (0%) 2 (50%) 2 (50%)
C. hemolyticum 77, 80 2 (1.6%) 68.5 ± 26.1 2 (100%) 2 (100%) 0 (0%) 1 (50%) 1 (50%)
p = 0.024
0 (0%) 0 (0%)
C. minutissimum 86, 91 2 (1.6%) 35.5 ± 6.3 1 (50%) 2 (100%) 0 (0%) 1 (50%) 0 (0%) 0 (0%) 2 (100%)
C amycolatum 6, 60 2 (1.6%) 81 ± 9.8 0 (0%)
p = 0.024
2 (100%) 0 (0%) 1 (50%) 0 (0%) 0 (0%) 1 (50%)
Total 129 (100%) 35.7 ± 22.9 93 (72.1%) 123 (94.6%) 25 (19.3%) 40 (31.0%) 10 (7.7%) 36 (27.9%) 73 (56.6%)
*Data derived from References 2–97 (specific citations listed in by-species citations, column 1). All p values are compared to the mean.
† Percentages of the total number of cases (within column 2). Note: All other percentages represent values for each Corynebacterium species (percentage within each row).
‡ Left sided endocarditis: Aortic or mitral valve endocarditis.
§Previous valvular disease other than valve replacement.
|| Nosocomial risk factors: presence of an intravascular access device, dialysis fistula, pacemaker, or presence of a prosthetic device other than a valveBMC Infectious Diseases 2007, 7:4 http://www.biomedcentral.com/1471-2334/7/4
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tions and death even in the setting of previous immuniza-
tion and modern antibiotic treatment regimens [52,64].
Of all Corynebacterium  species,  C. striatum endocarditis
was associated with the greatest likelihood of survival,
with more than three quarter of cases surviving the infec-
tion. In contrast, only one third of C. pseudodiphtheriticum
cases, and one in six TCD cases survived.
There are several limitations to this study which should be
considered. This search was limited to English language
journals and did not include cases published in other lan-
guages. We recognize that classification of isolates and
nomenclature for Corynebacterium may have changed over
the time period that is encompassed by the source publi-
cations included in our analysis, and that new molecular
analysis techniques have led to the reclassification of
some isolates, and may impact our findings. Similarly, we
recognize our acceptance of cases as endocarditis is based
on source publication reports and we did not personally
review the original microbiology, pathology, or imaging
studies on these cases. These are well-recognized intrinsic
limitations to retrospective studies and reviews of pub-
lished data. While every effort was made for accuracy, we
are limited to the information available in these pub-
lished reports, and we can not predict how additional
unpublished cases would affect our findings. This is
equally true for the cases where insufficient detailed data
forced exclusion from the analysis. It is possible that the
associations described in this study could change as more
information is available. This is especially true for those
species that were least encountered but kept in our analy-
sis (e.g., C. hemolyticum, C. minutissimum, and C. xerosis) or
excluded because we could only identify a single case for
this unique species (C. tuscaniae, C. accolens, and C. pyo-
genes).
Conclusion
Our study reveals a number of hitherto fore unknown spe-
cies-specific associations between risk factors and out-
comes in Corynebacterium  endocarditis, including for
demographic factors (gender and age), clinical factors
(nosocomial risk factors, prosthetic valves), as well as out-
comes (need for valve replacement and survival). Clini-
cians would be wise to keep these organisms in mind as
rare causes of endocarditis, particularly when managing
patients who present with bacteremia due to gram posi-
tive rods.
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